Midgard Science

Labs / Assays & in vitro testing

ADViRNA

Worcester, MA, United States · advirna.com

ADViRNA develops and provides oligonucleotide therapeutics services for researchers in academia, biotech, and pharma. It supports projects from target identification and design through synthesis, screening, biodistribution analysis, and preclinical candidate validation. The company is based in Worcester, Massachusetts.

They take quote requests through a form on their website with project details. Their quote form

What they offer

  • Strategic Experimental Planning

    Expert consultation for design, troubleshooting, and delivery strategies.

  • Oligonucleotide Design

    Targeted design services for siRNAs and ASOs, including sequence prioritization and filtering.

  • Oligonucleotide Synthesis

    Custom synthesis of siRNAs, ASOs, and other oligonucleotides with chemical modifications and conjugation options.

  • Oligonucleotide Screening

    High-throughput screening of siRNAs and ASOs to identify potent candidates and validate knockdown.

  • Custom Assay Development

    Development of assays for molecular and functional readouts such as ELISA, western blotting, cell viability, qPCR, and reporter assays.

  • HYBRID-ON™ Oligonucleotide Detection Assay

    Detection and quantification of modified siRNAs and ASOs in complex biological samples.

  • Biodistribution Analysis

    Tissue detection and biodistribution assessment using the HYBRID-ON platform.

  • Precision Data Analysis

    Scientist-curated data outputs from raw values to publication-ready figures.

  • In Vivo Study Coordination

    Coordination of in vivo study design, synthesis, and downstream sample analysis through a CRO network.

  • siRNA Reagents

    Validated and non-validated siRNA products, including starter kits and custom targets.

What they work on

Modalities
Oligonucleotide, mRNA
Species and models
human, mouse, rat, rabbit, ocular tissues, primary neurons, cardiomyocytes
Assays and studies
qPCR, dual-luciferase psiCHECK reporter, ELISA, Western blotting, cell viability assessment, RNA-seq, biodistribution detection
Instruments and platforms
TaqMan, dual-luciferase psiCHECK system
Scale and capacity
1-10 nmol, 10-200 nmol, 0.2-2 umol, 1 to 1000+ candidates, 5 nmol
Therapeutic areas
neurological, cardiac, metabolic, oncological, immunological
Turnaround
most screens are completed within two weeks of receiving materials
What to send
target gene · species · therapeutic modality (siRNA/ASO) · program stage · key constraints or questions
Type
CRO
Sites
Worcester, United States
Serves
global
Address
17 Briden Street, Suite 102 Worcester, MA 01609
Founded
2007

Similar labs. Tetrad DISCOVERY, Alcami, Axela Biosciences, Inc, AxisPharm

Found in a contract services directory. Listing built from advirna.com. Work here? Claim this listing.

ADViRNA · Midgard Science